Combined periprocedural evaluation of CRP and TNF-alpha enhances the prediction of clinical restenosis and major adverse cardiac events in patients undergoing percutaneous coronary interventions.

International journal of molecular medicine

Volumn 16, Issue 1, 2005, Pages 173-180

  Kubica, Jacek ^a   Kozinski, Marek ^a   Krzewina Kowalska, Anna ^a   Zbikowska Gotz, Magdalena ^a   Dymek, Grazyna ^a   Sukiennik, Adam ^a   Piasecki, Radoslaw ^a   Bogdan, Maria ^a   Grzesk, Grzegorz ^a   Chojnicki, Maciej ^a   Dziedziczko, Andrzej ^a   Sypniewska, Grazyna ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

AGED; ANGINA PECTORIS; ARTICLE; BLOOD; CLINICAL TRIAL; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CORONARY RESTENOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 23844543663     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)